Vera Codazzi

Chiesi Farmaceutici is an international group based in Parma, research-oriented, with over 85 years of experience, present in 31 countries. The Chiesi Group researches, develops and markets innovative drugs in three specific areas: AIR (products and services in the respiratory field, from infants to adults), RARE (innovative solutions and personalized services to improve the quality of life of patients with rare and ultra-rare diseases) and CARE (products and services to support specialist care, personal care and well-being). Since 2019 Chiesi is a certified B Corp, while, in 2018, they have changed their legal status to a Benefit Company, realizing the desire to measure their impact on society and the environment, combining the need to generate value for the business to acting as a positive force for the community in which we live. Challenge Chiesi, one of the top 50 pharmaceutical companies in the world, is focused on addressing diseases through its three main therapeutic areas: AIR, RARE, and CARE. One of the core issues lie in the collection and processing of patient data for patient journey and clinical trials optimization. For Chiesi it is key to collect reliable data (GDPR and HIPAA compliant) from internal and external sources and elaborate/conditionate them to improve three specific phases of the patient journey: early diagnosis and prevention, therapy personalization/monitoring/efficacy, and a sustainable product lifecycle in their therapeutic areas. The goal is to develop a system that can collect and process data from internal sources, key stakeholders (such as clinics and hospitals), and external datasets to provide a digital solution (e.g., AI) that enables doctors to support patients throughout their journey, offering diagnoses, treatments and follow-ups, personalizing care pathways in hospitals, and enable patients to follow a correct treatment. The ideal solution could also support the doctor offering forecasts and suggestion for prevention and unlocking a way to allow the best patients recruitment in clinical trials. Objectives Scouting a data collection, conditioning, storage, and processing solution that supports medical operators in personalizing patient journey and patient care, from patient selection for clinical trials to prevention strategies and therapy customization, Looking for solutions with TRL 6 - Technology demonstrated in relevant environment, Chiesi is interested in collaborating with startups/scaleups to co-develop a PoC or to launch pilot projects together